comparemela.com

Latest Breaking News On - Obesity treatment - Page 2 : comparemela.com

Phenomix Sciences Raises $7 8M to Acclerate Obesity Precision Medicine Adoption

NeuroBo to Present Latest Pre-Clinical Data on Cardiometabolic Assets, DA-1241 and DA-1726, Targeting MASH and Obesity, at Scientific Conferences in June

/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.